Tristan  Sissung, Ph.D., M.S.
Tristan Sissung, Ph.D., M.S.
Staff Scientist

Center for Cancer Research
National Cancer Institute

Building 10, Room 5A01
Bethesda, MD 20892
301-594-5606

General clinical and molecular pharmacogenetics characterization using samples and data collected from individuals participating on clinical trials in the Medical Oncology Branch (NCI), and from preclinical models (e.g. mice, and cell lines) in order to characterize genetic findings in humans.

Areas of Expertise
preclinical models

General clinical and molecular pharmacogenetics characterization using samples and data collected from individuals participating on clinical trials in the Medical Oncology Branch (NCI), and from preclinical models (e.g. mice, and cell lines) in order to characterize genetic findings in humans.

Dr. Sissung received his B.S. In biochemistry and his M.S. in organic chemistry from the University of California at Riverside. He earned a Ph.D. in genetics from The George Washington University. Following his post-doctoral fellowship at the National Cancer Institute, Dr. Sissung became a staff scientist in the Clinical Pharmacology Program, within the Clinical Center, at NCI. Dr. Sissung has focused his research on pharmacogenetics and molecular genetics. Dr. Sissung has over 40 peer-reviewed publications and holds 4 patents.

Summary

General clinical and molecular pharmacogenetics characterization using samples and data collected from individuals participating on clinical trials in the Medical Oncology Branch (NCI), and from preclinical models (e.g. mice, and cell lines) in order to characterize genetic findings in humans.

Areas of Expertise
preclinical models

Research

General clinical and molecular pharmacogenetics characterization using samples and data collected from individuals participating on clinical trials in the Medical Oncology Branch (NCI), and from preclinical models (e.g. mice, and cell lines) in order to characterize genetic findings in humans.

Biography

Dr. Sissung received his B.S. In biochemistry and his M.S. in organic chemistry from the University of California at Riverside. He earned a Ph.D. in genetics from The George Washington University. Following his post-doctoral fellowship at the National Cancer Institute, Dr. Sissung became a staff scientist in the Clinical Pharmacology Program, within the Clinical Center, at NCI. Dr. Sissung has focused his research on pharmacogenetics and molecular genetics. Dr. Sissung has over 40 peer-reviewed publications and holds 4 patents.